Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Gene Therapy for Pleural Malignancies
| Conditions: | Pleural Mesothelioma|Metastatic Pleural Effusions |
| Start Date: | March 1, 2006 |
| Phase: | Phase I |
| Status: | Active, not recruiting |
| NCT ID: | NCT00299962 |
| Study Type: | Interventional |
| Intervention: | Biological: Adenoviral-mediated Interferon-beta|Biological: SCH 721015 |
| Study Design: | Allocation: Non-Randomized|Control: Active Control|Endpoint Classification: Safety Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | University of Pennsylvania|National Cancer Institute (NCI)|Biogen Idec |
| Ages: | Adult|Senior |
| Enrollment: | 18 |
| Funded By: | Other|NIH|Industry |
| First Received: | March 3, 2006 |
| End Date: | April 1, 2023 |
| Last Updated: | September 29, 2010 |
| Last Verified: | September 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
